- Home
- TILE vs BLFS Comparison
TILE vs BLFS Comparison
Compare TILE & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TILE
- BLFS
- Stock Information
- Founded
- TILE 1973
- BLFS 1987
- Country
- TILE United States
- BLFS United States
- Employees
- TILE N/A
- BLFS N/A
- Industry
- TILE Home Furnishings
- BLFS Medical/Dental Instruments
- Sector
- TILE Consumer Discretionary
- BLFS Health Care
- Exchange
- TILE Nasdaq
- BLFS Nasdaq
- Market Cap
- TILE 1.1B
- BLFS 1.2B
- IPO Year
- TILE N/A
- BLFS 1989
- Fundamental
- Price
- TILE $20.45
- BLFS $24.05
- Analyst Decision
- TILE Buy
- BLFS Strong Buy
- Analyst Count
- TILE 1
- BLFS 7
- Target Price
- TILE $30.00
- BLFS $30.57
- AVG Volume (30 Days)
- TILE 425.5K
- BLFS 567.8K
- Earning Date
- TILE 05-02-2025
- BLFS 05-08-2025
- Dividend Yield
- TILE 0.20%
- BLFS N/A
- EPS Growth
- TILE 44.62
- BLFS N/A
- EPS
- TILE 1.46
- BLFS N/A
- Revenue
- TILE $1,323,328,000.00
- BLFS $82,254,000.00
- Revenue This Year
- TILE $4.21
- BLFS $20.32
- Revenue Next Year
- TILE $5.25
- BLFS $19.98
- P/E Ratio
- TILE $13.61
- BLFS N/A
- Revenue Growth
- TILE 5.41
- BLFS 8.44
- 52 Week Low
- TILE $14.13
- BLFS $17.15
- 52 Week High
- TILE $27.34
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- TILE 66.08
- BLFS 53.63
- Support Level
- TILE $18.77
- BLFS $21.13
- Resistance Level
- TILE $20.42
- BLFS $25.60
- Average True Range (ATR)
- TILE 0.64
- BLFS 1.52
- MACD
- TILE 0.26
- BLFS 0.00
- Stochastic Oscillator
- TILE 100.00
- BLFS 73.83
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.